First Tracks Biotherapeutics Stock (NASDAQ:TRAX)
Previous Close
$44.03
52W Range
$14.72 - $49.91
50D Avg
$30.35
200D Avg
$25.38
Market Cap
$1.54B
Avg Vol (3M)
$742.18K
Beta
3.37
Div Yield
-
TRAX Company Profile
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.